NP101 Sumatriptan Iontophoretic Transdermal Patch
PROT-15-NP101-006
Phase 3 small_molecule completed
Quick answer
NP101 Sumatriptan Iontophoretic Transdermal Patch for Migraine Disorders is a Phase 3 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 2 ClinicalTrials.gov record(s).
Program details
- Company
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- Indication
- Migraine Disorders
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed